Growth Metrics

Gevo (GEVO) Asset Writedowns and Impairment (2022 - 2026)

Gevo (GEVO) reported Asset Writedowns and Impairment of $533000.0 for Q1 2026, up 987.76% on a QoQ basis from $49000.0 in Q4 2022.

Gevo (GEVO) has 2 years of Asset Writedowns and Impairment data on file, last reported at $533000.0 in Q1 2026.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $533000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $582000.0 (changed N/A YoY) and the FY2022 annual result came in at $24.7 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment advanced to $533000.0 in Q1 2026 per GEVO's latest filing, from $49000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $24.7 million in Q3 2022 and bottomed at $49000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn
10 Gevo 434.60 Mn 362.65 Mn 22.72 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 533,000.00
Mar 31, 2026 533,000.00
Dec 31, 2022 49,000.00
Dec 31, 2022 49,000.00
Sep 30, 2022 24.70 Mn
Sep 30, 2022 24.70 Mn